Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.2.1.23 (
beta-galactosidase
)
14,648
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Specific antibodies to Xenopus laevis
bone morphogenetic protein-4
(xBMP-4) were raised by immunizing rabbits with a fusion protein of bacterial
beta-galactosidase
and xBMP-4. The antibodies were used to detect xBMPs expressed in mammalian cells by Western blotting. The antibodies were found to recognize xBMP-4 specifically and not to cross-react with either xBMP-2 or xBMP-7 which are similar to xBMP-4. In addition, the antibodies recognized dimeric xBMP-4 whereas our previous antibodies recognized the reduced form only. The present antibodies detected an immunoreactive 27 kDa protein in extracts of developing Xenopus embryos from oocyte to tailbud embryo. The xBMP-4 peptide appeared to be monomeric in structure because the molecular weight did not shift upon reduction of disulfide bond(s).
...
PMID:Immunodetection of Xenopus bone morphogenetic protein-4 in early embryos. 831 52
Degradable matrices containing expression plasmid DNA [gene-activated matrices (GAMs)] were implanted into segmental gaps created in the adult rat femur. Implantation of GAMs containing
beta-galactosidase
or luciferase plasmids led to DNA uptake and functional enzyme expression by repair cells (granulation tissue) growing into the gap. Implantation of a GAM containing either a
bone morphogenetic protein-4
plasmid or a plasmid coding for a fragment of parathyroid hormone (amino acids 1-34) resulted in a biological response of new bone filling the gap. Finally, implantation of a two-plasmid GAM encoding
bone morphogenetic protein-4
and the parathyroid hormone fragment, which act synergistically in vitro, caused new bone to form faster than with either factor alone. These studies demonstrate for the first time that repair cells (fibroblasts) in bone can be genetically manipulated in vivo. While serving as a useful tool to study the biology of repair fibroblasts and the wound healing response, the GAM technology may also have wide therapeutic utility.
...
PMID:Stimulation of new bone formation by direct transfer of osteogenic plasmid genes. 865 Jan 65
Serum-free mouse embryo (SFME) cells are an epidermal growth factor (EGF)-dependent established line derived from brains of 16-d-old Balb/c mouse embryos. SFME cells grow indefinitely in serum-free medium without replicative senescence, chromosomal abnormalities, or malignant transformation. SFME cells express nestin, a neural stem cell marker, under serum-free conditions. Exposure to serum or transforming growth factor beta (TGF-beta) leads to a marked increase in differentiation toward the astrocytic lineage with expression of glial fibrillary acidic protein and other astrocyte markers. In this study, we show that treatment of SFME cells with
bone morphogenetic protein-4
(
BMP-4
), another member of the TGF-beta family, led to differentiation toward a neuronal lineage under conditions of low mitogenic stimulation (0.5 ng/mL) by EGF and fibroblast growth factor. Maximum mitogenic stimulation with 50 ng/mL EGF blocked the
BMP-4
effect on neuronal differentiation, but did not block TGF-beta-induced expression of markers of the astrocytic lineage.
BMP-4
treatment also enhanced the activity of the neuron-specific enolase (NSE) promoter in SFME-NSE-lacZ cells that carry the gene for bacterial
beta-galactosidase
under the control of the NSE promoter. Extended
BMP-4
treatment caused SFME cells to express a neuronal phenotype synthesizing gamma-aminobutyric acid. These results indicate that SFME cells have the capacity to generate both neurons and astrocytes in vitro, which resemble the behavior of EGF-dependent multipotential stem cells in the central nervous system, and establish a relationship between effects of
BMP-4
and degree of mitogenic stimulation by other peptide growth factors.
...
PMID:Mitogen limitation and bone morphogenetic protein-4 promote neurogenesis in SFME cells, an EGF-dependent neural stem cell line. 1905 72